Primary Record
Hyperoside
- In stock
- 639 g
- Purity
- 99.8 %
- CAS
- 482-36-0
Compound Identifiers & Properties
- CAS
- 482-36-0
- PubChem CID
- 5281643
- SMILES
- C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O)O
- Canonical SMILES
- O=c1c(O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12
Names & Synonyms
- Hyperoside
- Hyperin
- Hyperosid
- Hyperozide
- Hyperasid
- 482-36-0
- Quercetin 3-galactoside
- quercetin galactoside
- Jyperin
- Quercetin-3-O-galactoside
- Quercetin-3-galactoside
- Isoquercitrin
- Isoquercitroside
- p Hyperin
- Hyperoside CRS
- Quercetin 3-D-galactoside
- quercetin 3-O-galactoside
- Hyperoside (Standard)
- AC1NQYSS
- quercetin-3-d-galactoside
- RefChem:5898
- Quercetin 3-O-beta-D-galactopyranoside
- MFCD00016933
- QUERCETIN 3-B-D-GALACTOSIDE
- UNII-8O1CR18L82
- CCRIS 9339
- CHEMBL251254
- OVSQVDMCBVZWGM-DTGCRPNFSA-N
- Quercetin 3-|A-Galactoside
- Quercetin 3-beta-D-galactopyranoside
- 8O1CR18L82
- HYPEROSIDE [USP-RS]
- BIDD:PXR0057
- Quercetin 3-beta-galactoside
- quercetin-3-O-D-galactoside
- CHEBI:67486
- MLS000759538
- C21H20O12
- jm5b01461, Compound 84
- Quercetin 3-O-beta-D-galactoside
- DTXSID501028789
- MEGxp0_000392
- orb1304944
- quercetin-3-o-galactopyranoside
- SCHEMBL1250514
- SK-6
- Quercetin 3-O-galactopyranoside
- NSC 407304
- SCHEMBL29509019
- SCHEMBL29611459
- ACon1_000623
- EINECS 207-580-6
- HY-N0452R
- quercetin-3-o-beta-d-galactoside
- BDBM429266
- HMS2051H17
- HY-N0452
- Quercetin 3-.beta.-D-galactopyranoside
- ZINC3973253
- HYPEROSIDE (REFERENCE GRADE)
- quercetin-3-beta-D-galactopyranoside
- 3-O-beta-D-galacopyranosyl quercetin
- BDBM50241367
- MSK000529
- NP1811
- quercetin 3-O-beta-D-glucopyranoside
- s5453
- quercetin 3-O-|A-D-galactopyranoside
- AKOS015896780
- ACN-035463
- AN-8426
- CCG-100970
- CID5281643
- EBC-457087
- MQ08114
- NC00220
- NSC-407304
- Quercetin-3-O-beta-D-galactopyranoside
- C21-H20-O12
- CID:5281643
- NCGC00168902-03
- AS-56199
- BC209737
- CPD000466394
- J12.400A
- Quercetin 3-O-.beta.-D-galactopyranoside
- S600
- SAM001246776
- SC-43872
- SID:53787995
- SMR000466394
- 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one
- QUERCETIN 3-O-.BETA.-D-GALACTOSIDE
- CS-0008982
- FT-0776643
- N1838
- NS00079301
- 2-(3,4-Dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one
- A12070
- C10073
- Quercetin 3-D-galactoside, >=97.0% (HPLC)
- AB00639910-03
- 482H360
- A827503
- C021304
- (1R,2R)-(-)-2-Amino-1-phenyl-1,3-propanediol
- 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
- 3,3',4',5,7-Pentahydroxyflavone 3-D-galactoside
- Hyperoside, primary pharmaceutical reference standard
- I07-0250
- Q5242815
- BRD-K84955386-001-01-1
- 3-O-b-D-Galactopyranosyloxy-3',4',5,7-tetrahydroxyflavone
- HYPEROSIDE (CONSTITUENT OF ST. JOHN'S WORT) [DSC]
- N0001-001114
- 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one
- 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4H-chromen-4-one
- 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(.beta.-D-galactopyranosyloxy)-5,7-dihydroxy-
- Hyperoside, United States Pharmacopeia (USP) Reference Standard
- 3 ,4 ,5,7-Tetrahydroxy-3-(beta-D-galactopyranosyloxy)flavone
- 3-(beta-D-Galactopyranosyloxy)-3 ,4 ,5,7-tetrahydroxyflavone
- 3-(beta-D-Galactopyranosyloxy)-5,7,3 ,4 -tetrahydroxyflavone
- HYPEROSIDE (CONSTITUENT OF HAWTHORN LEAF WITH FLOWER) [DSC]
- 2-[3,4-bis(oxidanyl)phenyl]-3-[(2S,3R,4S,5R,6R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5,7-bis(oxidanyl)chromen-4-one
- Hyperoside, 98%, from Abelmoschus manihot (L.) Medic. - 20MG 20mg
- 2-(3,4-Dihydroxyphenyl)-3-(b-D-galactopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one
- 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl beta-D-galactopyranoside
- 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl hexopyranoside #
- 4H-1-Benzopyran-4-one,2-(3,4-dihydroxyphenyl)-3-(b-D-galactopyranosyloxy)-5,7-dihydroxy-
- 2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-((2S,4R,5R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-chromen-4-one
- 2-(3,4-dihydroxyphenyl)- 3-(alpha-D-galactopyranosyloxy)-5,7-dihydroxy-4H- 1-benzopyran-4-one
- 2-(3,4-DIHYDROXYPHENYL)-3-(.BETA.-D-GALACTOPYRANOSYLOXY)-5,7-DIHYDROXY-4H-1-BENZOPYRAN-4-ONE
- 2-(3,4-dihydroxyphenyl)-3-(alpha-D-galactopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one
- 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxychromen-4-one
- 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-((2S,4R,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxychromen-4-one
- 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-((2S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxychromen-4-one
- 207-580-6
- 21637-25-2
- 3,3 inverted exclamation marka,4 inverted exclamation marka,5,7-Pentahydroxyflavone 3-D-galactoside
- 3-(beta-D-Galactopyranosyloxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one
- 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-
- 5,7-Dihydroxy-2-(3,4-dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-4H-1-benzopyran-4-one
- 65549-68-0
- Hyperoside; 3-O-|A-D-galactopy ranosylquercetin; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one
- J6O